Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s What Hedge Funds Think About Ameris Bancorp (ABCB)

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. We get to see hedge funds’ thoughts towards the market and individual stocks by aggregating their quarterly portfolio movements and reading their investor letters. In this article, we will particularly take a look at what hedge funds think about Ameris Bancorp (NASDAQ:ABCB).

Is Ameris Bancorp (NASDAQ:ABCB) a healthy stock for your portfolio? The best stock pickers are getting less optimistic. The number of bullish hedge fund positions retreated by 1 lately. Our calculations also showed that abcb isn’t among the 30 most popular stocks among hedge funds. ABCB was in 17 hedge funds’ portfolios at the end of March. There were 18 hedge funds in our database with ABCB positions at the end of the previous quarter.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 40 percentage points since May 2014 through May 30, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 30.9% through May 30, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Paul Marshall Marshall Wace

Paul Marshall of Marshall Wace

Let’s review the key hedge fund action surrounding Ameris Bancorp (NASDAQ:ABCB).

Hedge fund activity in Ameris Bancorp (NASDAQ:ABCB)

Heading into the second quarter of 2019, a total of 17 of the hedge funds tracked by Insider Monkey were long this stock, a change of -6% from the fourth quarter of 2018. By comparison, 8 hedge funds held shares or bullish call options in ABCB a year ago. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were adding to their stakes considerably (or already accumulated large positions).

No of Hedge Funds with ABCB Positions

The largest stake in Ameris Bancorp (NASDAQ:ABCB) was held by Polaris Capital Management, which reported holding $37.5 million worth of stock at the end of March. It was followed by Mendon Capital Advisors with a $34.9 million position. Other investors bullish on the company included Marshall Wace LLP, Brant Point Investment Management, and Citadel Investment Group.

Since Ameris Bancorp (NASDAQ:ABCB) has faced falling interest from the smart money, we can see that there was a specific group of money managers that decided to sell off their positions entirely heading into Q3. Interestingly, Jim Simons’s Renaissance Technologies dumped the largest investment of all the hedgies monitored by Insider Monkey, totaling about $4.7 million in stock, and David Costen Haley’s HBK Investments was right behind this move, as the fund sold off about $0.6 million worth. These moves are interesting, as total hedge fund interest fell by 1 funds heading into Q3.

Let’s check out hedge fund activity in other stocks similar to Ameris Bancorp (NASDAQ:ABCB). We will take a look at Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), Hostess Brands, Inc. (NASDAQ:TWNK), MSG Networks Inc (NYSE:MSGN), and Atrion Corporation (NASDAQ:ATRI). This group of stocks’ market values are closest to ABCB’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
MDRX 21 200430 3
TWNK 24 132667 4
MSGN 21 261088 1
ATRI 8 92684 -2
Average 18.5 171717 1.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 18.5 hedge funds with bullish positions and the average amount invested in these stocks was $172 million. That figure was $126 million in ABCB’s case. Hostess Brands, Inc. (NASDAQ:TWNK) is the most popular stock in this table. On the other hand Atrion Corporation (NASDAQ:ATRI) is the least popular one with only 8 bullish hedge fund positions. Ameris Bancorp (NASDAQ:ABCB) is not the least popular stock in this group but hedge fund interest is still below average. Our calculations showed that top 20 most popular stocks among hedge funds returned 6.2% in Q2 through June 19th and outperformed the S&P 500 ETF (SPY) by nearly 3 percentage points. A small number of hedge funds were also right about betting on ABCB as the stock returned 11.2% during the same time frame and outperformed the market by an even larger margin.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...